Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

3.0K
3.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.2K
4.2K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

6.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.3K
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Context-dependent selection sculpts mutational landscapes in the normal lung.

Research square·2026
Same author

A plasma proteomic signature of cancer-related sarcopenia implicates the IGFBP axis in muscle dysfunction.

Molecular cancer·2026
Same author

Spatial architecture contributes to failure of bulk biomarker-guided neoadjuvant immunotherapy selection in bladder cancer: The DUTRENEO study.

Cell reports. Medicine·2026
Same author

Plasma signals of lung tumor promotion for molecular cancer prevention.

Cell·2026
Same author

Estimation of protein melting temperatures using small-ladder replica exchange simulations.

The Journal of chemical physics·2026
Same author

Subclonal immune evasion in non-small cell lung cancer.

Cancer cell·2026

Related Experiment Video

Updated: Mar 18, 2026

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:50

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

1.1K

Cancer in 4D: toward Spatiotemporal Hallmark Ecosystems.

Mustafa Sibai1, Martin Zacharias2, Nicholas McGranahan3

  • 1Josep Carreras Leukaemia Research Institute, Badalona, Spain; Barcelona Supercomputing Center (BSC), Barcelona, Spain.

Trends in Cancer
|March 16, 2026
PubMed
Summary

Cancer evolution is better understood as dynamic Spatiotemporal Hallmark Ecosystems, not static traits. This new view explains treatment resistance and guides targeted therapies by considering the tumor microenvironment.

More Related Videos

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
11:00

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

18.0K
3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer
10:51

3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer

Published on: January 5, 2021

5.2K

Related Experiment Videos

Last Updated: Mar 18, 2026

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:50

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

1.1K
Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
11:00

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

18.0K
3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer
10:51

3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer

Published on: January 5, 2021

5.2K

Area of Science:

  • Oncology
  • Cancer Biology
  • Evolutionary Biology

Background:

  • The established Hallmarks of Cancer framework describes tumor capabilities but lacks spatial and temporal context.
  • A static view cannot explain variations in tumor progression, persistence of premalignant states, or emergent therapeutic resistance.

Purpose of the Study:

  • To introduce Spatiotemporal Hallmark Ecosystems as a novel framework for understanding cancer evolution.
  • To redefine the functional unit of selection in cancer from individual cells to ecosystems.
  • To resolve paradoxes in cancer development and resistance by incorporating microenvironmental influences.

Main Methods:

  • Conceptual framework development: Shifting focus from cellular phenotypes to ecosystem dynamics.
  • Analysis of tumor progression and therapeutic resistance through an ecological lens.
  • Integration of spatial and temporal dimensions into cancer hallmark analysis.

Main Results:

  • Identified hallmarks as context-dependent phenotypes influenced by local tissue and microenvironment.
  • Explained divergent mutation outcomes and persistent premalignant states via ecosystem dynamics.
  • Characterized therapeutic resistance as a result of ecological buffering within tumor architecture.

Conclusions:

  • Spatiotemporal Hallmark Ecosystems offer a more comprehensive understanding of cancer evolution.
  • This framework provides a basis for developing predictive biomarkers and spatially-aware therapeutic strategies.
  • Targeting the structural stability of the tumor ecosystem is a promising therapeutic avenue.